resveratrol has been researched along with Sepsis in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (5.26) | 29.6817 |
| 2010's | 22 (57.89) | 24.3611 |
| 2020's | 14 (36.84) | 2.80 |
| Authors | Studies |
|---|---|
| Du, J; Wang, C; Yuan, J | 1 |
| Fu, J; Simayi, A; Wang, X; Xu, G; Zhao, X | 1 |
| Bo, H; Liu, S; Lv, G; Wang, S; Wang, Y; Yan, B; Yang, Y; Ye, C; Yin, Y; Yuan, J; Zhang, W | 1 |
| Liu, JF; Qin, KW; Wu, CL; Zhang, C; Zhou, LJ | 1 |
| Arikan Söylemez, ES; Attar, R; Doğanyiğit, Z; Okan, A; Uçar, S; Yilmaz, S | 1 |
| Dashti, F; Karimi, A; Kiani Chalmardi, F; Mahmoodpoor, A; Sanaie, S; Sefidmooye Azar, P; Vajdi, M | 1 |
| Jin, H; Sun, K; Xing, Y; Yu, F; Zhao, W; Zheng, X | 1 |
| Demir, Ö; Doğanay, S; Huyut, MT; Kalindemirtaş, FD; Kariper, İA; Kurt, N; Özgeriş, B; Üstündağ, H | 1 |
| Callahan, LA; Schroder, EA; Supinski, GS | 1 |
| Chen, K; Lin, K; Shang, X; Wang, L; Xu, J; Yu, R; Zhang, Y; Zhu, P | 1 |
| D'souza, J; Jadhav, V; Mittra, I; Pal, K; Pancholi, N; Parab, S; Raghuram, GV; Rane, B; Shaikh, A; Shende, S; Shinde, S; Siddiqui, S; Tidke, P | 1 |
| Bellot, GL; Chong, TW; Goh, FY; Iskandar, K; Pervaiz, S; Schwarz, H; Tai, JJ; Wang, B; Wong, SC | 1 |
| An, S; Cai, S; Chen, Z; Deng, Z; Fang, H; Hu, H; Huang, Q; Sun, M; Wu, C; Wu, J; Zeng, Z; Zhou, Z | 1 |
| Gulifeire, T; Li, X; Wang, Y; Yang, C; Yu, X | 1 |
| Liu, K; Liu, M; Mao, L; Wang, K; Wang, N; Xiao, X; Yang, L; Zhang, H; Zou, J | 1 |
| Qureshi, AA; Qureshi, N; Reddy, NS; Silswal, N | 1 |
| Wang, X; Wang, Y; Zhang, L; Zhang, R | 1 |
| Bu, QD; Che, L; Jiang, W; Liu, XM; Luan, H; Luo, CJ; Luo, F; Ma, RX; Sun, JP; Xu, Y; Zhang, H; Zhang, W | 1 |
| Bai, X; Cao, M; He, T; Li, L; Liu, M | 1 |
| Cao, Y; Cheng, J; Feng, J; Huang, R; Li, Q; Li, T; Lin, Y; Sun, J; Wu, L; Wu, Q; Xiang, G; Ye, Q; Zhang, J; Zhang, M | 1 |
| Chang, KC; Cho, GJ; Chung, HT; Han, J; Joe, Y; Kim, HJ; Kim, HK; Kim, SK; Ryter, SW; Yu, JK; Zheng, M | 1 |
| Chen, Z; Jing, H; Li, M; Li, Z; Lu, Y; Peng, J; Tian, X; Wang, G; Xu, W; Yao, J; Zhang, X | 1 |
| Buechler, NL; McCall, CE; Vachharajani, VT; Wang, X; Yoza, BK | 1 |
| Huajie, Z | 1 |
| An, R; Li, H; Shen, G; Sun, L; Xi, C; Xu, J; Zhang, S; Zhang, W; Zhao, L | 1 |
| Cao, D; Gan, Y; Tao, S; Xie, H; Zeng, Q | 1 |
| Chen, GD; Chen, XP; Yu, WD | 1 |
| Chen, Z; Dai, X; Gao, Y; Wei, S; Xu, S; Zeng, Z; Zhang, Q; Zhao, KS | 1 |
| Cha, MH; Kim, JR; Kim, YR; Oh, DR; Oh, WK; Rhee, JH | 1 |
| Gacar, G; Gacar, N; Gocmez, S; Komsuoglu, I; Tugay, M; Utkan, NZ; Utkan, T | 1 |
| Azorín-Ortuño, M; Espín, JC; García-Conesa, MT; Larrosa, M; Tomás-Barberán, F; Yañez-Gascón, MJ | 1 |
| Gokden, N; Holthoff, JH; Mayeux, PR; Seely, KA; Wang, Z | 1 |
| Venkatachalam, MA; Weinberg, JM | 1 |
| dos Santos, CC; Furmli, S; Haitsma, JJ; Horvath, E; Hu, P; Kuiper, JW; Leong-Poi, H; Masoom, H; Parker, TG; Plötz, FB; Shan, Y; Slutsky, AS; Smeding, L | 1 |
| Fernandes, CJ; Santucci Assunção, M | 1 |
| Aydin, S; Bacanli, M; Başaran, AA; Başaran, N; Şahin, T; Taner, G | 1 |
| Alican, I; Cetinel, S; Gedik, N; Kolgazi, M; Sener, G | 1 |
| Alattar, MH; Choudhry, MA; Dallal, O; Muraskas, JK; Namak, SY; Ravindranath, TM; Sayeed, MM | 1 |
3 review(s) available for resveratrol and Sepsis
| Article | Year |
|---|---|
A comprehensive insight into the molecular and cellular mechanisms of action of resveratrol on complications of sepsis a systematic review.
Topics: Antioxidants; Humans; Oxidative Stress; Resveratrol; Sepsis | 2023 |
Mitochondria and Critical Illness.
Topics: Acute Lung Injury; Alarmins; Antioxidants; Cesium; Critical Illness; DNA, Mitochondrial; Humans; Melatonin; Mitochondria; Muscle, Skeletal; Muscular Diseases; Organelle Biogenesis; Resveratrol; Sepsis | 2020 |
Research progress on SIRT1 and sepsis.
Topics: Animals; Glucosides; Humans; Inflammation; Phenols; Resveratrol; Sepsis; Signal Transduction; Sirtuin 1; Xanthones | 2019 |
35 other study(ies) available for resveratrol and Sepsis
| Article | Year |
|---|---|
Resveratrol alleviates acute lung injury through regulating PLSCR-3-mediated mitochondrial dysfunction and mitophagy in a cecal ligation and puncture model.
Topics: Acute Lung Injury; Animals; Antioxidants; Cecum; Disease Models, Animal; Humans; Ligation; Lung; Male; Mice; Mitochondria; Mitophagy; Phospholipid Transfer Proteins; Resveratrol; Sepsis | 2021 |
Resveratrol mediates the miR-149/HMGB1 axis and regulates the ferroptosis pathway to protect myocardium in endotoxemia mice.
Topics: Animals; Endotoxemia; Ferroptosis; HMGB1 Protein; Iron; Lipopolysaccharides; Mice; MicroRNAs; Myocardium; Reactive Oxygen Species; Resveratrol; Sepsis | 2022 |
Resveratrol glycoside mediates microglial endoplasmic reticulum stress to mitigate LPS-induced sepsis-associated cognitive dysfunction.
Topics: Animals; Cognitive Dysfunction; Endoplasmic Reticulum Stress; Glycosides; Lipopolysaccharides; Mice; Microglia; Resveratrol; Sepsis; Sepsis-Associated Encephalopathy | 2023 |
Resveratrol Prevents
Topics: Animals; Blotting, Western; Mice; Necroptosis; Resveratrol; Sepsis; Vibrio vulnificus | 2023 |
Evaluation of the protective role of resveratrol against sepsis caused by LPS via TLR4/NF-κB/TNF-α signaling pathways: Experimental study.
Topics: Animals; Lipopolysaccharides; Male; NF-kappa B; Rats; Resveratrol; Sepsis; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2023 |
Combination Therapy with Resveratrol and Celastrol Using Folic Acid-Functionalized Exosomes Enhances the Therapeutic Efficacy of Sepsis.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Exosomes; Folic Acid; Lipopolysaccharides; Mice; Pentacyclic Triterpenes; Resveratrol; Sepsis | 2023 |
ENHANCED EFFICACY OF RESVERATROL-LOADED SILVER NANOPARTICLE IN ATTENUATING SEPSIS-INDUCED ACUTE LIVER INJURY: MODULATION OF INFLAMMATION, OXIDATIVE STRESS, AND SIRT1 ACTIVATION.
Topics: Animals; Chemical and Drug Induced Liver Injury, Chronic; Cytokines; Inflammation; Metal Nanoparticles; NF-kappa B; Oxidative Stress; Rats; Resveratrol; Sepsis; Silver; Sirtuin 1; Vascular Endothelial Growth Factor A | 2023 |
Resveratrol Protects the Myocardium in Sepsis by Activating the Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway and Inhibiting the Nuclear Factor-κB (NF-κB) Signaling Pathway.
Topics: Animals; Apoptosis; Cardiomyopathies; China; Chromones; Disease Models, Animal; Heart; Male; Morpholines; Myocardium; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; Sepsis; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2019 |
Cell-free chromatin particles released from dying host cells are global instigators of endotoxin sepsis in mice.
Topics: Animals; Cell Death; Cell-Free Nucleic Acids; Chromatin; Copper; Cytokines; Deoxyribonuclease I; DNA Damage; Endotoxins; Female; Histones; Inflammation Mediators; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Nanoparticles; Resveratrol; Sepsis | 2020 |
Resveratrol attenuates TLR-4 mediated inflammation and elicits therapeutic potential in models of sepsis.
Topics: Animals; Cytokines; Disease Models, Animal; Humans; Inflammation; Inflammation Mediators; Male; Mice, Inbred C57BL; Monocytes; Resveratrol; Sepsis; Signal Transduction; Toll-Like Receptor 4 | 2020 |
SIRT1 attenuates sepsis-induced acute kidney injury via Beclin1 deacetylation-mediated autophagy activation.
Topics: Acetylation; Acute Kidney Injury; Animals; Autophagy; Beclin-1; Cell Line; Disease Models, Animal; Enzyme Activation; Enzyme Activators; Glucosides; Humans; Kidney Tubules, Proximal; Male; Mice, Inbred C57BL; Resveratrol; Sepsis; Signal Transduction; Sirtuin 1; Stilbenes; Time Factors | 2021 |
[Effects of resveratrol-mediated inhibition of NOD-like receptor protein 3 inflammasomevia activating silent information regulator 1 on the injury of intestinal mucosal barrier function after sepsis].
Topics: Animals; Caco-2 Cells; Humans; Interleukins; Intestinal Mucosa; Male; NLR Family, Pyrin Domain-Containing 3 Protein; NLR Proteins; Rats; Rats, Wistar; Resveratrol; Sepsis; Sirtuin 1; Tumor Necrosis Factor-alpha | 2021 |
Resveratrol protects against early polymicrobial sepsis-induced acute kidney injury through inhibiting endoplasmic reticulum stress-activated NF-κB pathway.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Biomarkers; Cell Line; Cytokines; Disease Models, Animal; Endoplasmic Reticulum Stress; Humans; Inflammation Mediators; Kidney Function Tests; Lipopolysaccharides; Male; Membrane Proteins; NF-kappa B; Protein Serine-Threonine Kinases; Rats; Resveratrol; Sepsis; Signal Transduction; Stilbenes | 2017 |
Resveratrol Downregulates Biomarkers of Sepsis Via Inhibition of Proteasome's Proteases.
Topics: Autophagy; Biomarkers; Cell Survival; Cells, Cultured; Humans; Lipopolysaccharides; Monocytes; Oligopeptides; Proteasome Endopeptidase Complex; Real-Time Polymerase Chain Reaction; Resveratrol; Sepsis; THP-1 Cells | 2018 |
Alleviation of Acute Lung Injury in Rats with Sepsis by Resveratrol via the Phosphatidylinositol 3-Kinase/Nuclear Factor-Erythroid 2 Related Factor 2/Heme Oxygenase-1 (PI3K/Nrf2/HO-1) Pathway.
Topics: Acute Lung Injury; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Chemokine CXCL2; Heme Oxygenase-1; Interleukin-10; Interleukin-18; Male; NF-E2-Related Factor 2; Oxidative Stress; Phosphatidylinositol 3-Kinase; Random Allocation; Rats; Rats, Wistar; Resveratrol; Sepsis; Signal Transduction; Stilbenes | 2018 |
Protective effects of resveratrol on acute kidney injury in rats with sepsis.
Topics: Acute Kidney Injury; Animals; Antioxidants; Disease Models, Animal; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Sepsis | 2020 |
Resveratrol reduces acute lung injury in a LPS‑induced sepsis mouse model via activation of Sirt1.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Disease Models, Animal; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Male; Matrix Metalloproteinase 9; Mice; Nitric Oxide Synthase Type II; Resveratrol; RNA Interference; RNA, Small Interfering; Sepsis; Sirtuin 1; Stilbenes; Up-Regulation | 2013 |
Resveratrol induces hepatic mitochondrial biogenesis through the sequential activation of nitric oxide and carbon monoxide production.
Topics: Animals; Antioxidants; Carbon Monoxide; Disease Models, Animal; Hep G2 Cells; Humans; Injections, Intraperitoneal; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Nitric Oxide; Resveratrol; Sepsis; Stilbenes; Tumor Cells, Cultured | 2014 |
Novel role of resveratrol: suppression of high-mobility group protein box 1 nucleocytoplasmic translocation by the upregulation of sirtuin 1 in sepsis-induced liver injury.
Topics: Acetylation; Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Nucleus; Cells, Cultured; Cytoplasm; Drug Evaluation, Preclinical; Gene Knockdown Techniques; Hepatocytes; HMGB1 Protein; Male; Molecular Targeted Therapy; Oxidative Stress; Rats, Sprague-Dawley; Resveratrol; Sepsis; Sirtuin 1; Stilbenes; Translocation, Genetic; Up-Regulation | 2014 |
Resveratrol attenuates microvascular inflammation in sepsis via SIRT-1-Induced modulation of adhesion molecules in ob/ob mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cecum; Cell Adhesion Molecules; Female; Inflammation; Intercellular Adhesion Molecule-1; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Platelet Adhesiveness; Resveratrol; Sepsis; Sirtuin 1; Stilbenes | 2015 |
[Effect of resveratrol on myocardial energy metabolism in sepsis rats].
Topics: Animals; Energy Metabolism; Heart; Lipopolysaccharides; Mitochondria, Heart; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Sepsis; Stilbenes | 2015 |
Resveratrol alleviates sepsis‑induced myocardial injury in rats by suppressing neutrophil accumulation, the induction of TNF‑α and myocardial apoptosis via activation of Sirt1.
Topics: Animals; Apoptosis; Cardiomyopathies; Disease Models, Animal; Male; Neutrophil Infiltration; Neutrophils; Rats; Resveratrol; Sepsis; Sirtuin 1; Stilbenes; Tumor Necrosis Factor-alpha | 2016 |
Protection of resveratrol on acute kidney injury in septic rats.
Topics: Acute Kidney Injury; Animals; Cytokines; Glomerular Filtration Rate; Kidney; Male; Protective Agents; Rats, Sprague-Dawley; Renal Circulation; Resveratrol; Sepsis; Sirtuin 1; Stilbenes; Transcription Factor RelA | 2017 |
SirT1 activator represses the transcription of TNF‑α in THP‑1 cells of a sepsis model via deacetylation of H4K16.
Topics: Acetylation; Cell Line; Drug Resistance, Neoplasm; Enzyme Activation; Gene Expression Regulation; Histones; Humans; Macrophages; Promoter Regions, Genetic; Protein Binding; Resveratrol; RNA, Messenger; Sepsis; Sirtuin 1; Stilbenes; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2016 |
SIRT1/3 Activation by Resveratrol Attenuates Acute Kidney Injury in a Septic Rat Model.
Topics: Acetylation; Acute Kidney Injury; Animals; Apoptosis; Carbazoles; Cecum; Disease Models, Animal; Enzyme Activation; Epithelial Cells; Female; Histone Deacetylase Inhibitors; Kidney Tubules; Ligation; Male; Mitochondria; Oxidative Stress; Punctures; Rats, Sprague-Dawley; Resveratrol; Sepsis; Signal Transduction; Sirtuin 1; Sirtuins; Stilbenes; Superoxide Dismutase | 2016 |
Resveratrol modulates RTX toxin-induced cytotoxicity through interference in adhesion and toxin production.
Topics: Animals; Bacterial Adhesion; Bacterial Toxins; Down-Regulation; Gene Expression Regulation, Bacterial; HeLa Cells; Host-Pathogen Interactions; Humans; Mice; Movement; Resveratrol; RNA, Messenger; Sepsis; Stilbenes; Vibrio Infections; Vibrio vulnificus | 2010 |
Effects of resveratrol on ileal smooth muscle reactivity in polymicrobial sepsis model.
Topics: Animals; Antioxidants; Cecum; Ileum; Interleukin-1; Ligation; Male; Muscle, Smooth; Rats; Rats, Wistar; Resveratrol; Sepsis; Stilbenes; Tumor Necrosis Factor-alpha | 2012 |
Lack of effect of oral administration of resveratrol in LPS-induced systemic inflammation.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antioxidants; Chromatography, Liquid; Endotoxins; Inflammation; Interleukin-1beta; Lipid Peroxidation; Lipopolysaccharides; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Sepsis; Stilbenes; Tandem Mass Spectrometry; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2011 |
Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury.
Topics: Acute Kidney Injury; Animals; Antioxidants; Blood Pressure; Disease Models, Animal; Epithelium; Glomerular Filtration Rate; Heart Rate; Kidney; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Microcirculation; Reactive Nitrogen Species; Resveratrol; Sepsis; Stilbenes; Survival Analysis; Time Factors; Vasodilator Agents | 2012 |
The tubule pathology of septic acute kidney injury: a neglected area of research comes of age.
Topics: Acute Kidney Injury; Animals; Antioxidants; Kidney; Male; Microcirculation; Resveratrol; Sepsis; Stilbenes | 2012 |
Salutary effect of resveratrol on sepsis-induced myocardial depression.
Topics: Animals; Cardiomyopathies; Cecum; Down-Regulation; Edema; Gene Expression; Heart Failure; Ligation; Male; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Myocardial Contraction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Random Allocation; Resveratrol; Sepsis; Stilbenes; Trans-Activators; Transcription Factors; Vasodilator Agents | 2012 |
In vino veritas? Pliny the Elder.
Topics: Animals; Heart Failure; Male; Myocardial Contraction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Sepsis; Stilbenes; Trans-Activators; Transcription Factors; Vasodilator Agents | 2012 |
Protective effects of resveratrol on sepsis-induced DNA damage in the lymphocytes of rats.
Topics: Animals; Antimutagenic Agents; Comet Assay; DNA Damage; DNA-Formamidopyrimidine Glycosylase; Lymphocytes; Rats; Rats, Wistar; Resveratrol; Sepsis; Stilbenes | 2013 |
Resveratrol reduces renal and lung injury caused by sepsis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cecum; Collagen; Disease Models, Animal; Female; Glutathione; Kidney; Kidney Diseases; L-Lactate Dehydrogenase; Ligation; Lung; Lung Diseases; Male; Malondialdehyde; Peroxidase; Rats; Rats, Sprague-Dawley; Resveratrol; Sepsis; Stilbenes; Tumor Necrosis Factor-alpha | 2006 |
Sepsis-induced alteration in T-cell Ca(2+) signaling in neonatal rats.
Topics: Animals; Animals, Newborn; Bacteroides Infections; Calcium; Concanavalin A; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Escherichia coli Infections; Isoenzymes; Lymphocyte Activation; Membrane Proteins; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Resveratrol; Sepsis; Signal Transduction; Spleen; Stilbenes; Sulfonamides; T-Lymphocytes | 2001 |